SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* Boyan Barry C. (Last) (First) (Middle) ONE TRIBOLOGY CENTER 102 WILLENBROCK ROAD (Street) OXFORD CONNECTICUT 06478 (City) (State) (Zip) UNITED STATES (Country)	2. Issuer Name and Ticker or Trading Symbol RBC Bearings INC [ RBC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	2a. Foreign Trading Symbol
	3. Date of Earliest Transaction (Month/Day/Year) 06/03/2026	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
	4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		S		555	D	$591.6283	3,751(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$211.59							07/15/2023(2)	07/15/2029	Common Stock	1,745		1,745	D
Option (right to buy)	$219.09							08/18/2024(3)	08/18/2030	Common Stock	2,000		2,000	D
Option (right to buy)	$181.58							02/08/2022	02/08/2028	Common Stock	1,145		1,145	D
Option (right to buy)	$256.23							09/09/2023(4)	09/09/2029	Common Stock	255		255	D
Option (right to buy)	$302.21							10/01/2025(5)	10/01/2031	Common Stock	2,000		2,000	D
Option (right to buy)	$565.22							05/19/2027(6)	05/19/2033	Common Stock	647		647	D

Explanation of Responses:

1. Includes 2,144 shares of restricted stock that vest according to the following schedule; 300 shares 1/2 of which vest on 7/15/2026 and 1/2 vest on 7/15/2027; 100 shares 1/2 of which vest on 9/9/2026 and 1/2 vest on 9/9/2027; 600 shares 1/3 of which vest on 8/18/2026, 1/3 vest on 8/18/2027 and 1/3 vest on 8/18/2028; 696 shares 1/4 of which vest on 10/1/2026, 1/4 vest on 10/1/2027, 1/4 vest on 10/1/2028 and 1/4 vest on 10/1/2029; 104 shares 1/4 of which vest on 11/20/2026, 1/4 vest on 11/20/2027, 1/4 vest on 11/20/2028 and 1/4 vest on 11/20/2029; and 344 shares 1/3 of which vest on 5/19/2027, 1/3 vest on 5/19/2028 and 1/3 vest on 5/19/2029.

2. All these options to purchase Common Stock are exerciseable except for 698 options that vest according to the following schedule: 1/2 vest on 7/15/2026 and 1/2 vest on 7/15/2027.

3. All these options to purchase Common Stock are exerciseable except for 1,200 options that vest according to the following schedule: 1/3 vest on 8/18/2026, 1/3 vest on 8/18/2027 and 1/3 vest on 8/18/2028.

4. All these options to purchase Common Stock are exerciseable except for 102 options that vest according to the following schedule: 1/2 vest on 9/9/2026 and 1/2 vest on 9/9/2027.

5. All these options to purchase Common Stock are exerciseable except for 1,600 options that vest according to the following schedule: 1/4 vest on 10/1/2026; 1/4 vest on 10/1/2027; 1/4 vest on 10/1/2028 and 1/4 vest on 10/1/2029.

6. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031.

Remarks:

	/s/John J. Feeney/attorney in fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)